Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease

被引:8
|
作者
Weissler, E. Hope [1 ]
Narcisse, Dennis, I [2 ]
Rymer, Jennifer A. [2 ]
Armstrong, Ehrin J. [3 ]
Secemsky, Eric [4 ]
Gray, William A. [5 ]
Mustapha, Jihad A. [6 ]
Adams, George L. [7 ]
Ansel, Gary M. [8 ]
Patel, Manesh R. [2 ]
Jones, W. Schuyler [2 ]
机构
[1] Duke Univ Hlth Syst, Div Vasc & Endovasc Surg, Durham, NC USA
[2] Duke Univ Hlth Syst, Div Cardiol, Durham, NC USA
[3] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA
[4] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA
[5] Lankenau Heart Inst, Main Line Hlth, Wynnewood, PA USA
[6] Adv Cardiac & Vasc Ctr Amputat Prevent, Grand Rapids, MI USA
[7] UNC REX Healthcare, Div Cardiol, Raleigh, NC USA
[8] OhioHealth, Columbus, OH USA
关键词
lower extremity intervention; endovascular intervention; peripheral artery disease; diabetes mellitus; chronic limb threatening ischemia;
D O I
10.1177/1538574420968671
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Patients with diabetes mellitus (DM) are known to be at higher risk for peripheral artery disease (PAD), amputations, and major adverse cardiovascular events, though it is unclear whether they are at any higher risk for repeat intervention. LIBERTY 360 offered an opportunity to study a real-world cohort of patients who underwent distal superficial femoral artery endovascular revascularizations. We aimed to describe patients with DM, their outcomes following peripheral vascular intervention, and the effect of DM on outcomes in the LIBERTY 360 cohort. Methods: LIBERTY 360 is a prospective, multi-center, non-randomized, mono-industry funded observational study of patients undergoing endovascular revascularization. Outcomes included 30-day and 1-year all-cause mortality, major amputation, target vessel/lesion revascularization, and a composite of those events. A multivariable regression model including DM was constructed to examine the effect of DM on outcomes. Multivariable survival estimates were made using Cox proportional hazards models. Results: A total of 1,204 patients were enrolled, of whom 727 had DM (60.4%). Patients with DM had significantly more comorbidities and a third required insulin for DM management. Patients with DM had more severe disease based on Rutherford classification at baseline. After adjusting for comorbidities and disease severity, DM patients had more frequent major amputations at 1 year (5.2% versus 1.2%; HR 2.71, 95%CI 1.05-6.98, p = 0.040). The 1-year rates of all-cause mortality and target vessel/lesion revascularization were not significantly higher for patients with DM. Conclusions: Diabetes mellitus was associated with increased major amputations at 1 year following endovascular revascularization after accounting for demographics, comorbidities, and PAD-related characteristics. Further research is needed to determine which aspects of PAD and DM are most strongly associated with poor outcomes following lower extremity revascularization.
引用
收藏
页码:124 / 134
页数:11
相关论文
共 50 条
  • [31] Impact of severe chronic kidney disease on outcomes of infrainguinal peripheral arterial intervention
    Patel, Virendra I.
    Mukhopadhyay, Shankha
    Guest, Julie M.
    Conrad, Mark F.
    Watkins, Michael T.
    Kwolek, Christopher J.
    LaMuraglia, Glenn M.
    Cambria, Richard P.
    JOURNAL OF VASCULAR SURGERY, 2014, 59 (02) : 368 - 375
  • [32] Platelet Hyperreactivity in Patients With Symptomatic Peripheral Artery Disease Undergoing Lower Extremity Revascularization
    Berger, Jeffrey S.
    Guo, Yu
    Rodriguez, Crystalann
    Lee, Angela
    Luttrell, Elliot
    O'Reilly, Deirdre
    Nardi, Michael
    Suarez, Yajaria
    Rockman, Caron
    CIRCULATION, 2018, 138
  • [33] Diabetes mellitus is not a contra-indication for peripheral vascular intervention in patients with leg ischaemia
    Ubbink, DT
    Tulevski, II
    Legemate, DA
    Jacobs, MJHM
    VASA-JOURNAL OF VASCULAR DISEASES, 1997, 26 (01): : 39 - 42
  • [34] Clinical outcomes of patients with and without chronic kidney disease undergoing endovascular revascularization of infrainguinal peripheral artery disease: Insights from the XLPAD registry
    Kabir, Ryan
    Vuppala, Suchith
    Liu, Yulun
    Tejani, Ishita
    Weideman, Rick
    Banerjee, Avantika
    Tsai, Shirling
    Huffman, Lynn
    Niazi, Khusrow
    Brilakis, Emmanouil S.
    Shishehbor, Mehdi H.
    Banerjee, Subhash
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (02) : 310 - 316
  • [35] CLINICAL OUTCOMES OF PATIENTS WITH AND WITHOUT CHRONIC KIDNEY DISEASE UNDERGOING ENDOVASCULAR REVASCULARIZATION OF INFRAINGUINAL PERIPHERAL ARTERY DISEASE: INSIGHTS FROM THE XLPAD REGISTRY
    Kabir, Ryan
    Dargham, Bassel Bou
    Liu, Yulun
    Tejani, Ishita
    Banerjee, Avantika
    Niazi, Khusrow
    Banerjee, Subhash
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1155 - 1155
  • [36] Improvement in patient reported outcome measures following supervised exercise therapy or peripheral vascular intervention for symptomatic peripheral artery disease
    Raja, Aishwarya
    Chowdhury, Mohsin
    Carroll, Brett
    Krawisz, Anna
    Schmaier, Alec
    Yeh, Robert
    Secemsky, Eric A.
    VASCULAR MEDICINE, 2020, 25 (03) : NP4 - NP4
  • [37] Outcomes of Infrainguinal Stents in Peripheral Arterial Disease
    Platt, N.
    Poskitt, K.
    Odedra, B.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [38] Peripheral arterial disease in patients with diabetes mellitus
    Mowla, Ashkan
    Bahrami, Amir
    Dastgheib, Seyed Alireza
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (07) : 707 - 708
  • [39] The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease
    Vig, S.
    Chitolie, A.
    Bevan, D.
    Dormandy, J.
    Thompson, M. M.
    Halliday, A.
    BRITISH JOURNAL OF SURGERY, 2006, 93 (05) : 577 - 581
  • [40] INTRAPLATELET SEROTONIN IN PATIENTS WITH DIABETES-MELLITUS AND PERIPHERAL VASCULAR-DISEASE
    BARRADAS, MA
    GILL, DS
    FONSECA, VA
    MIKHAILIDIS, DP
    DANDONA, P
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (04) : 399 - 404